CVRX
CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.
CVRX
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2001-01-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Website Url:
http://www.cvrx.com
Total Employee:
101+
Status:
Active
Contact:
(763)416-2840
Total Funding:
390.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Mobile Non Scaleable Content Nginx Sitelinks Search Box
Similar Organizations
BONESUPPORT
BONESUPPORT is a medical technology company that develops injectable osteoconductive biomaterials for the treatment of fragility fractures.
Chronic Disease Research Group
CDRG is a clinician-guided biomedical research group engaged in observational studies for the investigation of chronic illnesses.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Medical Device Innovations
Medical Device Innovations is a U.S.-based company that develops technologies for the treatment of atrial fibrillation and more.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Orthocon
ORTHOCON is a medical therapeutics company developing absorbable products for orthopaedic and spine surgeries.
POLYNEURON
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
Preora Healthcare
Preora Healthcare is a medical device company focused on developing nanocytology technology for the early detection and treatment of cancer.
Relox Medical
Relox Medical is an R&D company developing drugs for the treatment and recovery of traumatic brain injury and stroke.
RICOVR Healthcare Inc.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
SuperDimension
SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Vensana Capital
Vensana Capital investment in Private Equity Round - CVRx
Treo Ventures
Treo Ventures investment in Private Equity Round - CVRx
Venrock
Venrock investment in Private Equity Round - CVRx
Hatteras Venture Partners
Hatteras Venture Partners investment in Private Equity Round - CVRx
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Private Equity Round - CVRx
New Enterprise Associates
New Enterprise Associates investment in Private Equity Round - CVRx
Gilde Healthcare
Gilde Healthcare investment in Private Equity Round - CVRx
Action Potential Venture Capital
Action Potential Venture Capital investment in Private Equity Round - CVRx
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series G - CVRx
Gilde Healthcare
Gilde Healthcare investment in Series G - CVRx
Official Site Inspections
http://www.cvrx.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CVRx"
CVRx | Barostim™ | Heart Failure Device Implant
CVRx offers a heart failure therapy option with Barostim™, the world’s first neuromodulation device for heart failure management. Learn more now!See details»
CVRx - Crunchbase Company Profile & Funding
CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and …See details»
Our Team | About Us - CVRx
Prior to joining CVRx®, he held various sales & marketing leadership roles in 3 international companies in the medical device sector (St. Jude Medical, Sorin Group and Boston Scientific) …See details»
Investor Relations - CVRx
Oct 29, 2024 CVRx® is a leader in the development of safe and effective therapies to address unmet needs in cardiovascular disease. Headquartered near Minneapolis, Minn., CVRx is …See details»
CVRx, Inc. (CVRX) Company Profile & Facts - Yahoo Finance
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The …See details»
CVRx - Funding, Financials, Valuation & Investors - Crunchbase
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
CVRx, Inc. (CVRX) Company Profile & Facts - Yahoo Finance
See the company profile for CVRx, Inc. (CVRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
CVRx Reports Fourth Quarter and Full Year 2022 Financial and …
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and …See details»
FAQs - CVRx
CVRx is a leader in innovative medical technologies that address unmet needs in cardiovascular diseases with safe and effective therapies that harness and harmonize the body’s natural …See details»
CVRx Announces Appointment of Kevin Hykes as President and …
Jan 31, 2024 Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors since 2022 MINNEAPOLIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- …See details»
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 …
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing …See details»
Contact Us - CVRx
Global Headquarters . 9201 West Broadway Avenue, Suite 650 Minneapolis, MN 55445, USA. Phone: +1 763-416-2840 Fax: +1 763-416-2841 Patient / Technical Support. Phone: +1 763 …See details»
CVRx, Inc. (CVRX) Stock Price, News, Quote & History - Yahoo …
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.See details»
Working at CVRx - Glassdoor
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. ... No real cons, just the typical challenges that come with being in …See details»
Join The CVRx Team | Careers | CVRx®
EEO statement: CVRx, Inc. provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without …See details»
CVRx, Inc. (CVRX) Stock Price, News, Quote & History - Yahoo …
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The …See details»
CVRx Reports First Quarter 2022 Financial and Operating Results
First Quarter 2022 Revenue of $4.1 million, a 43% Increase Over Prior Year. MINNEAPOLIS, April 25, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial …See details»
CVRx (CVRX) Earnings Date and Reports 2025 - MarketBeat
Nov 22, 2024 In the previous quarter, CVRx (NASDAQ:CVRX) missed the analysts' consensus estimate of ($0.45) by $0.12 with a reported earnings per share (EPS) of ($0.57). Learn more …See details»
CVRx Reports First Quarter 2023 Financial and Operating Results
Mar 31, 2022 MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, …See details»
CVRx Reports Third Quarter 2022 Financial and Operating Results
Nov 1, 2022 Third quarter 2022 revenue of $6.2 million, an 82% increase over prior year. MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial …See details»